Sekar Kathiresan

Calculating genetic risk scores for obesity, new insights about leukemia drugs, and more.

Powerful new tool may enable new opportunities for biological understanding and clinical interventions

Diversifying population-level genetic data beyond Europeans will expand the power of polygenic scores.

Learning more about lipid loci, and putting genetic-guided medicine to the test.

Looking at a brain tumor from all the angles, and what urine can teach us about heart disease risk.

Tests based on millions of common DNA variants reveal hidden disease risk; researchers work to bring them to the clinic

Through “polygenic risk scoring,” researchers can identify people at high risk for disease, even if they don’t present other warning signs; method shows potential for use in the clinic

Building on multiple genome-wide association studies, researchers identify a distant regulator of the EDN1 gene that influences risk for five vascular disorders.